| A | B | C | |
|---|---|---|---|
| 1 | Main | ||
| 2 | Brand Name | INCB13739 | |
| 3 | Generic Name | ||
| 4 | Indication | Type II Diabetes | |
| 5 | Mechanism | 11 Beta HSD1 inhibitor. Details into mechanism - how does it affect insulin. | |
| 6 | Administration | ||
| 7 | Competition | ||
| 8 | Economics | Did Amgen have a drug like this? With biovitrum? | |
| 9 | IP | ||
| 10 | History | ||
| 11 | Clinical Trials | ||
| 12 | Phase IIa | ||
| 13 | complete inhibition of 11 Beta HSD1 activity in adipose and liver tissue | ||
| 14 | plans to move forward with a Phase IIa, two-step insulin clamp | ||
| 15 | trial in 1Q07 to assess the impact of this drug on glucose | ||
| 16 | metabolism in both the liver and the periphery |